The following is a summary of the Moolec Science SA (MLEC) Q3 2024 Earnings Call Transcript:
Financial Performance:
Revenue increased year-over-year from nil to approximately $1.3 million.
Gross margin stood at 18%.
Operational cash flow was approximately $2.7 million with a decrease in cash utilization year-over-year.
Moolec's cash position strengthened by approximately $2 million due to additional funding.
Business Progress:
Achieved USDA-APHIS regulatory approval for Piggy Sooy.
Initiated field trials for Piggy Sooy in three different U.S. locations.
GLASO is in pre-commercial stages with intended market penetration in 2025.
Two U.S. patents granted for SPC2 technology extending protection till 2041.
Opportunities:
Moolec's Piggy Sooy provides a sustainable alternative to traditional livestock farming, reducing water and CO2 emissions.
Expected commercial adoption and scaling of Piggy Sooy and GLASO in the forthcoming years.
Risks:
Dependence on the success and commercial acceptance of Piggy Sooy and other products still in pre-commercial or early commercial stages.
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.